FDA approves Keytruda and Padcev combo for bladder cancer treatment
Go back to FDA approves Keytruda and Padcev combo for bladder cancer treatment| Merck & Co. (NYSE: MRK) | Delayed: 147.98 -0.1 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.08 | 52 Week High | $65.46 | |||
| Open | $148.16 | 52 Week Low | $47.97 | |||
| Day High | $151.46 | P/E | 100.67 | |||
| Day Low | $147.90 | EPS | $1.47 | |||
| Volume | 10,328,757 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.41 +0.23 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.18 | 52 Week High | $37.39 | |||
| Open | $28.20 | 52 Week Low | $28.25 | |||
| Day High | $28.85 | P/E | 17.22 | |||
| Day Low | $28.20 | EPS | $1.65 | |||
| Volume | 34,753,620 | |||||
